BRAIN Act of 2021
Summary
Bringing Regulatory Advances Into Neuroscience Act of 2021 or the BRAIN Act of 2021 This bill requires the Food and Drug Administration (FDA) to establish the Neuroscience Center of Excellence. The center must develop and implement processes to coordinate FDA activities related to a major disease area or areas affecting the brain or central nervous system. The FDA must also establish and maintain the Neuroscience Translation Working Group to advise the center. If the FDA terminates the center, the working group shall advise the FDA.
Bill status
in committee
1 of 4 stages cleared
Introduction
Sep 2021
Committee Review
Floor Vote
President
Introduced Sep 30, 2021
Last action Oct 1, 2021
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
4
Key actions
0
Committee
2
Oct 1, 2021
Committee
Referred to the Subcommittee on Health.
lower
Sep 30, 2021
Committee
Referred to the House Committee on Energy and Commerce.
lower
Sep 30, 2021
Introduced
Introduced in House
lower
1 primary · 6 co-sponsors
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about HR 5435
Scope: US
Hi! I can help you understand HR 5435. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline